stonks4u
Sign up free
ACH logo

ACH Accendra Health, Inc.

New York Stock Exchange · Medical - Distribution · Healthcare

$0.95
-0.15 (-13.55%)

Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive …

Market Cap: $72.82Mwww.accendrahealth.com

Price (90d)

$1.26
$1.26$2.14$3.01$3.89
May 4Aug 11

Signal Score (90d)

112
112
Aug 10Aug 10

Quote

Day Range
$0.93 – $1.09
52-Week Range
$0.93 – $5.85
Volume
$2.87M
Market Cap
$72.82M
50-Day Avg
$3.01
200-Day Avg
$2.82
Prev Close
$1.10
Open
$1.08

Valuation & Ratios

P/E Ratio
-0.20
EPS
$-14.31
P/B Ratio
-0.47
P/S Ratio
0.08
Debt/Equity
-4.85
Current Ratio
0.58
Dividend Yield
+0.0%
Gross Margin
+46.7%

Returns & Efficiency

Return on Equity
+238.8%
Return on Assets
-44.9%
FCF Yield
-140.8%
EV/EBITDA
9.86

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.76B$-1.10B$-14.31
2024$10.70B$-362.69M$-4.73
2023$10.33B$-41.30M$-0.54
2022$9.96B$22.39M$0.30
2021$9.79B$221.59M$3.05

Social Signal Score

63
5d
—
30d
63
4 mentions
-66.7%
60d
63
4 mentions
-59.0%
90d
63
4 mentions
-56.7%
news: 4

Earnings

Thu, Oct 29(in 2 months)

Consensus estimate $0.09 per share

4of 7 quarters beat consensus

Typical surprise +3.8% (median, so one quarter with a near-zero estimate can't distort it)

  • Mon, Aug 10$-0.19 vs $-0.08miss
  • Mon, May 11$-0.04 vs $-0.06beat
  • Thu, Feb 19$0.21 vs $0.22miss
  • Thu, Oct 30$0.25 vs $0.23beat
  • Mon, Aug 11$0.26 vs $0.27miss
  • Thu, May 8$0.23 vs $0.20beat

Estimates and results for ACH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ACHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (4)

  • Newsseekingalpha.com·5d ago·Positive

    Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newsbusinesswire.com·5d ago·Neutral

    Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company's ability to preserve its net operating loss carryforwards (“NOLs”) and certain other tax attributes. A company generall

    View source ↗
  • Newsbusinesswire.com·5d ago·Positive

    Accendra Health Reports Second Quarter 2026 Financial Results RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Throughout the second quarter, we moved farther along toward the complete separation from Owen

    View source ↗
  • Newsbusinesswire.com·5d ago·Positive

    Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company's Board of Directors before the end of the year. The Board of Director

    View source ↗